Search Results

There are 1853 results for: content related to: Association of PAI-1 gene polymorphism with survival and chemotherapy-related vascular toxicity in testicular cancer

  1. You have free access to this content
    PAI-1 Gene 4G/5G Polymorphism and Risk of Type 2 Diabetes in a Population-based Sample

    Obesity

    Volume 14, Issue 5, May 2006, Pages: 753–758, James B. Meigs, Josée Dupuis, Chunyu Liu, Christopher J. O'Donnell, Caroline S. Fox, Sekar Kathiresan, Stacey B. Gabriel, Martin G. Larson, Qiong Yang, Alan G. Herbert, Peter W. F. Wilson, DaLi Feng, Geoffrey H. Tofler and L. Adrienne Cupples

    Article first published online : 6 SEP 2012, DOI: 10.1038/oby.2006.85

  2. The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children

    Clinical Endocrinology

    Volume 62, Issue 5, May 2005, Pages: 607–610, Sibel Tulgar Kınık, F. Belgin Ataç, Hasibe Verdi, Sedat Çetintaş, Feride İ. Şahin and Namık Özbek

    Article first published online : 7 APR 2005, DOI: 10.1111/j.1365-2265.2005.02268.x

  3. You have free access to this content
    The 4G/4G genotype of the 4G/5G polymorphism of the type-1 plasminogen activator inhibitor (PAI-1) gene is a determinant of penetrating behaviour in patients with Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 17, Issue 8, April 2003, Pages: 1039–1047, M. Sans, D. Tàssies, M. PellisÉ, G. Espinosa, L. Quintó, J. M. Piqué, J. C. Reverter and J. Panés

    Article first published online : 9 APR 2003, DOI: 10.1046/j.1365-2036.2003.01536.x

  4. You have free access to this content
    The 4G/4G Genotype of the PAI-1 (Serpine-1) 4G/5G Polymorphism Is Associated With Decreased Lung Allograft Utilization

    American Journal of Transplantation

    Volume 12, Issue 7, July 2012, Pages: 1848–1854, A. Sapru, J. G. Zaroff, L. Pawlikowska, K. D. Liu, K. K. Khush, L. A. Baxter-Lowe, V. Hayden, R. L. Menza, M. Convery, V. Lo, A. Poon, H. Kim, W. L. Young, J. Kukreja, M. A. Matthay and for the DOGMATIC Study Investigators

    Article first published online : 5 MAR 2012, DOI: 10.1111/j.1600-6143.2012.03996.x

  5. Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation

    Clinical & Experimental Allergy

    Volume 39, Issue 8, August 2009, Pages: 1136–1144, Z. Ma, D. Paek and C. K. Oh

    Article first published online : 5 MAY 2009, DOI: 10.1111/j.1365-2222.2009.03272.x

  6. Plasminogen activator inhibitor-1 4G/5G polymorphism in infertile women with and without endometriosis

    Acta Obstetricia et Gynecologica Scandinavica

    Volume 90, Issue 5, May 2011, Pages: 473–477, RUBENS P. GONÇALVES-FILHO, ARIEL BRANDES, DENISE M. CHRISTOFOLINI, TATIANA G. LERNER, BIANCA BIANCO and CAIO P. BARBOSA

    Article first published online : 14 MAR 2011, DOI: 10.1111/j.1600-0412.2011.01086.x

  7. Association between Plasminogen Activator Inhibitor-1 Gene Polymorphisms and Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis

    American Journal of Reproductive Immunology

    Volume 73, Issue 4, April 2015, Pages: 292–300, Hui Chen, Shuping Nie and Ming Lu

    Article first published online : 24 SEP 2014, DOI: 10.1111/aji.12321

  8. You have free access to this content
    PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects

    British Journal of Haematology

    Volume 111, Issue 1, October 2000, Pages: 122–128, Rafael Seguí, Amparo Estellés, Yolanda Mira, Francisco España, Piedad Villa, Cristina Falcó, Amparo Vayá, Salvador Grancha, Fernando Ferrando and Justo Aznar

    Article first published online : 4 AUG 2008, DOI: 10.1111/j.1365-2141.2000.02321.x

  9. You have free access to this content
    The 4G/5G PAI-1 polymorphism influences the endothelial response to IL-1 and the modulatory effect of pravastatin

    Journal of Thrombosis and Haemostasis

    Volume 4, Issue 8, August 2006, Pages: 1798–1803, C. RONCAL, J. ORBE, M. BELZUNCE, J. A. RODRíGUEZ and J. A. PÁRAMO

    Article first published online : 26 JUL 2006, DOI: 10.1111/j.1538-7836.2006.02031.x

  10. You have free access to this content
    The plasminogen activator inhibitor-1 −675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH Study

    Journal of Thrombosis and Haemostasis

    Volume 1, Issue 11, November 2003, Pages: 2322–2329, I. Juhan-Vague, P. E. Morange, C. Frere, M. F. Aillaud, M. C. Alessi, E. Hawe, S. Boquist, P. Tornvall, J. S. Yudkin, E. Tremoli, M. Margaglione, G. Di Minno, A. Hamsten, S. E. Humphries and on behalf of the hifmech study group

    Article first published online : 1 OCT 2003, DOI: 10.1046/j.1538-7836.2003.00458.x

  11. Plasminogen Activator Inhibitor 1 4G/5G and −844G/A Variants in Idiopathic Recurrent Pregnancy Loss

    American Journal of Reproductive Immunology

    Volume 70, Issue 3, September 2013, Pages: 246–252, Kalthoum Magdoud, Viviana G. Herbepin, Renaud Touraine, Wassim Y. Almawi and Touhami Mahjoub

    Article first published online : 22 MAR 2013, DOI: 10.1111/aji.12116

  12. Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer

    Journal of Surgical Oncology

    Volume 104, Issue 7, 1 December 2011, Pages: 755–759, Chung-Kuang Su, Kun-Tu Yeh, Chao-Bin Yeh, Po-Hui Wang, Esther Shih-Chu Ho, Ming-Chih Chou, Kai-Cheng Liu, Shun-Fa Yang and Yu-Chiao Yi

    Article first published online : 14 JUL 2011, DOI: 10.1002/jso.22035

  13. The PAI-1 4G/5G and ACE I/D Polymorphisms and Risk of Recurrent Pregnancy Loss: A Case–Control Study

    American Journal of Reproductive Immunology

    Volume 72, Issue 6, December 2014, Pages: 571–576, Jin Ju Kim, Young Min Choi, Sung Ki Lee, Kwang Moon Yang, Eun Chan Paik, Hyeon Jeong Jeong, Jong Kwan Jun, Ae Ra Han and Min A Hong

    Article first published online : 31 JUL 2014, DOI: 10.1111/aji.12302

  14. The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children

    European Journal of Haematology

    Volume 66, Issue 1, January 2001, Pages: 57–62, Ulrike Nowak-Göttl, Ronald Sträter, Andrea Kosch, Arnold Von Eckardstein, Rosemarie Schobess, Petra Luigs, Petra Nabel, Heinrich Vielhaber, Karin Kurnik, Ralf Junker and the Childhood Stroke Study Group

    Article first published online : 7 JUL 2008, DOI: 10.1034/j.1600-0609.2001.00338.x

  15. You have free access to this content
    The 4G/4G genotype at nucleotide position −675 in the promotor region of the plasminogen activator inhibitor 1 (PAI-1) gene is less frequent in young patients with minor stroke than in controls

    British Journal of Haematology

    Volume 110, Issue 2, August 2000, Pages: 469–471, G. Endler, W. Lalouschek, M. Exner, G. Mitterbauer, D. Häring and C. Mannhalter

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2141.2000.02164.x

  16. You have free access to this content
    The −675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients

    Allergy

    Volume 61, Issue 2, February 2006, Pages: 234–238, A. Pampuch, K. Kowal, A. Bodzenta-Lukaszyk, A. Di Castelnuovo, L. Chyczewski, M. B. Donati and L. Iacoviello

    Article first published online : 15 SEP 2005, DOI: 10.1111/j.1398-9995.2005.00948.x

  17. Recurrent Pregnancy Loss, Plasminogen Activator Inhibitor-1 (-675) 4G/5G Polymorphism and Antiphospholipid Antibodies in Czech Women

    American Journal of Reproductive Immunology

    Volume 70, Issue 1, July 2013, Pages: 54–58, Ivan Subrt, Zdenka Ulcova-Gallova, Monika Cerna, Marketa Hejnalova, Jitka Slovanova, Katarina Bibkova and Zdenka Micanova

    Article first published online : 27 FEB 2013, DOI: 10.1111/aji.12099

  18. Plasminogen activator inhibitor 1 gene polymorphisms and mirtazapine responses in Koreans with major depression

    Asia-Pacific Psychiatry

    Volume 1, Issue 3, December 2009, Pages: 143–151, Hun Soo Chang, Hwa-Young Lee, Byung-Joo Ham, Rhee-Hun Kang, Yoo-Jung Jeong, Hyang-Mi Kim, Sang-Woo Hahn and Min-Soo Lee

    Article first published online : 27 OCT 2009, DOI: 10.1111/j.1758-5872.2009.00025.x

  19. You have free access to this content
    The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe preeclampsia

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue 4, April 2005, Pages: 686–691, A. GERHARDT, T. W. GOECKE, M. W. BECKMANN, K. J. WAGNER, B. TUTSCHEK, R. WILLERS, H-G. BENDER, R. E. SCHARF and R. B. ZOTZ

    Article first published online : 7 MAR 2005, DOI: 10.1111/j.1538-7836.2005.01226.x

  20. The 4G/4G PAI-1 genotype is associated with elevated plasma PAI-1 levels regardless of variables of the metabolic syndrome and smoking status. A population-based study in Spanish population

    Diabetes, Obesity and Metabolism

    Volume 9, Issue 1, January 2007, Pages: 134–135, M. J. Martínez-Calatrava, M. T. Martínez-Larrad, C. Zabena, J. L. González-Sánchez, C. Fernández-Pérez and M. Serrano-Ríos

    Article first published online : 11 APR 2006, DOI: 10.1111/j.1463-1326.2006.00584.x